cabozantinib in mrcc
Published 6 years ago • 270 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
2:12
results of a trial comparing cabozantinib and sunitinib in mrcc
-
2:47
cabozantinib in mrcc
-
6:30
the rationale for using cabozantinib
-
3:21
cabosun trial: cabozantinib vs sunitinib for renal cell carcinoma
-
2:02
how cabozantinib is being used in practice for patients with rcc
-
5:26
mrcc: impact of cabosun and checkmate-214
-
4:14
first-line targeted therapy in mrcc
-
2:12
cabozantinib improves pfs in metastatic renal cell carcinoma
-
3:16
cabosun: upfront use of cabozantinib for mrcc
-
3:01
frontline treatment standard in mrcc
-
2:22
moa and management of any adverse effects of cabozantinib
-
1:32
dr. meric-bernstam on the activity of telaglenastat and cabozantinib in mrcc
-
6:30
cabozantinib plus nivolumab for first-line mrcc
-
1:35
checkmate-9er shows efficacy of nivolumab/cabozantinib combo in rcc
-
1:43
clinical rationale for tki choice in mrcc
-
59:55
renal cell carcinoma: past, present, and future
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
1:06
dr. toni choueiri on nivolumab and cabozantinib becoming first-line therapies in rcc
-
0:53
carina: cabozantinib post first-line immune-oncology cpi-containing combination in arcc